Can Long-Term PPI Use Cause Knee Pain?
No, there is no established causal relationship between long-term proton pump inhibitor (PPI) use and knee pain. The available evidence does not support a direct link between PPIs and musculoskeletal pain in the knee joint.
Evidence Review
Direct Evidence on PPIs and Joint Pain
- No credible mechanism exists linking PPIs to knee pain or osteoarthritis 1, 2, 3.
- The most comprehensively studied adverse effects of long-term PPI use include gastrointestinal infections, rebound acid hypersecretion, potential micronutrient deficiencies (vitamin B12, magnesium, calcium), and possible increased fracture risk—but not joint pain 2, 3.
- Multiple systematic reviews of PPI safety have not identified knee pain or arthralgia as recognized adverse effects 1, 2, 3.
Theoretical Connection Through Iron Deficiency
- One speculative hypothesis suggests PPIs may interfere with iron absorption by altering duodenal pH, potentially leading to iron deficiency 4.
- Iron deficiency has been associated with restless legs syndrome (RLS), which can cause deep "achy pain" in the legs, typically described as being in the shin bones between knee and ankle 4.
- However, this proposed PPI-iron-RLS pain pathway is purely theoretical with no robust direct evidence to support it 4.
- RLS-associated pain is characteristically worse at rest, relieved by movement, and occurs primarily at night—a distinct pattern from typical knee pain 4.
Hip Fracture Data (Not Knee Pain)
- Some observational studies have suggested a possible association between long-term PPI use and hip fracture risk, theoretically through decreased calcium absorption 5, 6.
- However, there is no data to support particular concern about fracture risk with long-term PPI use, and this relates to bone density issues, not joint pain 7.
- Even if bone effects exist, they would manifest as fracture risk, not knee pain 5, 6.
Clinical Approach to Knee Pain in PPI Users
Evaluate for Actual Causes of Knee Pain
- Osteoarthritis is the most common cause of knee pain and should be managed according to established guidelines with core treatments (exercise, weight loss if overweight, patient education) followed by pharmacological options if needed 8, 9.
- For persistent knee pain requiring NSAIDs, PPIs are actually recommended as gastroprotection in patients with gastrointestinal risk factors (age ≥60 years, history of peptic ulcer disease, concurrent anticoagulants or corticosteroids) 8, 5, 9.
Assess PPI Indication
- Review whether the patient has a definitive ongoing indication for PPI therapy such as Barrett's esophagus, severe erosive esophagitis (LA grade C/D), or gastroprotection for high-risk NSAID users 10, 11.
- Patients without definitive indications should be considered for PPI deprescribing through gradual tapering or abrupt discontinuation 10, 11.
- Do not discontinue PPIs in patients with Barrett's esophagus, severe erosive esophagitis, or those requiring gastroprotection while on NSAIDs for knee pain 10, 11.
Common Pitfalls to Avoid
- Do not attribute knee pain to PPI use without thoroughly evaluating for common causes of knee pain (osteoarthritis, meniscal injury, ligamentous injury, inflammatory arthritis) 8, 9.
- Do not discontinue necessary PPI therapy based on unfounded concerns about knee pain, especially in patients with definitive indications or those requiring gastroprotection for NSAID use 10, 11.
- If iron deficiency is suspected (fatigue, pallor, restless legs symptoms), check serum ferritin levels rather than assuming PPI causation 6, 4.
- Be aware that if a patient requires NSAIDs for knee osteoarthritis and has GI risk factors, continuing the PPI is appropriate gastroprotection 8, 5, 9.